Cargando…
LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway
Temozolomide (TMZ) is the most commonly used alkylating agent in glioma chemotherapy. However, growing resistance to TMZ remains a major challenge for clinicians. Recent evidence emphasizes the key regulatory roles of non-coding RNAs (lncRNAs and miRNAs) in tumor biology, including the chemoresistan...
Autores principales: | Du, Peng, Zhao, Haiting, Peng, Renjun, Liu, Qing, Yuan, Jian, Peng, Gang, Liao, Yiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587918/ https://www.ncbi.nlm.nih.gov/pubmed/28831025 http://dx.doi.org/10.1042/BSR20170696 |
Ejemplares similares
-
lncRNA XIST promotes glioma proliferation and metastasis through miR-133a/SOX4
por: Luo, Chixing, et al.
Publicado: (2020) -
LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma
por: Chen, Yusheng, et al.
Publicado: (2023) -
Long Noncoding RNA OR7E156P/miR-143/HIF1A Axis Modulates the Malignant Behaviors of Glioma Cell and Tumor Growth in Mice
por: Zhao, Haiting, et al.
Publicado: (2021) -
A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction
por: Zheng, Peng-Fei, et al.
Publicado: (2022) -
Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma
por: Peng, Yanguo, et al.
Publicado: (2020)